Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine

Background: Subjects with previous COVID-19 have augmented post-vaccination responses. However, the antibody response in COVID-naïve subjects from Southeast Asia is not well known. Methods: 77 COVID-naïve vaccinees were tested with a full antibody panel [spike antibodies (total (T-Ab), IgG, IgM) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Chin-Shern, Phua, Soon Kieng, Liang, Ya-Li, Oh, Helen May-Lin, Aw, Tar-Choon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622758/
https://www.ncbi.nlm.nih.gov/pubmed/34835172
http://dx.doi.org/10.3390/vaccines9111241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622758/
https://www.ncbi.nlm.nih.gov/pubmed/34835172
http://dx.doi.org/10.3390/vaccines9111241

Ejemplares similares